1.      Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, McCabe CH, Van de Werf  F and Braunwald E for the TIMI Study Group. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation, 2000; 101:125-130.

 

2.      Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. The association between white blood cell count, epicardial blood flow, myocardial perfusion and clinical outcomes in the setting of acute MI. A TIMI 10B substudy. Circulation. 2000 Nov 7;102(19):2329-34.

 

3.      Gibson CM, Cohen D, Cohen E, Liu H, Murphy S, Marble SJ, Lorenz T, Kitt M, Tcheng JE for the ESPRIT study Group. Treatment with Eptifibatide and Coronary Flow Reserve (CFR) Following Elective Stent Placement: An ESPRIT Substudy. Am J Cardiol 2001, Jun 1;87(11):1293-5.

 

4.      Gibson CM, Murphy SA, Hynes C, Marble SJ, Cohen DJ, Cohen E,  Lui HK, Kitt MM, Lorenz TJ,  and Tcheng JE  for the ESPRIT study group. Relationship of CK-MB Release to TIMI Myocardial Perfusion Grade Following Intracoronary Stent Placement: An ESPRIT Substudy.  Am Heart J. 2002 Jan;143(1):106-110.

 

5.      Angeja BG, Gunda M, Murphy SA, Sobel BE, Rundle AC, Syed M,  Asfour A, Borzak S, Gourlay SG, Barron HV, Gibbons RJ, Gibson CM for the LIMIT AMI Study Group. TIMI Myocardial Perfusion Grade and ST Segment Resolution: Association with Infarct Size as Assessed by Single Photon Emission Computed Tomography Imaging. Circulation. 2002 Jan 22;105(3):282-5.

 

6.      Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E for the TIMI Study Group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation, 2002; 105:1909-1913.

 

7.      Michaels AM, Appleby M, Dauterman K, Ports TA, Chou TM, Gibson CM. Pretreatment with Intragraft Verapamil Prior to Percutaneous Coronary Intervention of Saphenous Vein Graft Lesions: Results of the Randomized, Controlled Vasodilator Prevention of No-Reflow (VAPOR) Trial. J Invasive Cardiol. 2002 Jun;14(6):299-302.

 

8.      Wong GC, Kraimer N, Pai R, James D, Murphy SA, Cannon CP, Gibson CM for the TACTICS-TIMI 18 Study Group. Elevations in Troponin T are Associated with Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy. Circulation. 2002;106:202-207.

 

9.      Murphy SA, Chen C, Gourlay S, Barron HV, Gibson CM. Impaired tissue level perfusion in the non-culprit artery territory in the setting of acute MI.  Am J Cardiol. 2003 Feb 1;91(3):325-8.

 

10.  Weber JE, Gibson CM, Murphy SA, Larkin GL, Hollander JE. Cocaine induced myocardial infarction is associated with reduced microvascular perfusion. Acad Emerg Med 2003 May;10(5):428-9.

 

11.  Wong GC, Frisch D, Murphy SA, Sabatine MS, Pai R, James D, Kraimer N, Katsiyiannis PT, Marble SJ, DiBattiste PT,  Demopoulos LA, Gourlay SG,  Barron HV, Cannon CP, Gibson CM, for the LIMIT AMI and TACTICS-TIMI 18 Study Groups. Time for Dye to Traverse the Epicardial Artery and the Myocardium in Acute ST Segment Elevation Myocardial Infarction Versus Unstable Angina / Non ST Elevation MI. Am J Cardiol  2003 May 15;91(10):1163-7.

 

12.  Gibson CM, de Lemos JA, Murphy SA, Marble SJ, Antman EM, Cannon CP. Methodologic and Clinical Validation of the TIMI Myocardial Perfusion Grade in Acute MI. J Thromb Thrombolysis. 2002;14(3):233-7.

 

13.  Choi JW, Gibson CM, Murphy SA, Davidson CJ, Kim RJ, Ricciardi M. Myonecrosis following stent placement: Association between impaired TIMI myocardial perfusion grade (TMPG) and MRI visualization of microinfarction. Catheter Cardiovasc Interv. 2004;61(4):472-6.

 

14.   Gibson CM, Karha J, Giugliano RP, Roe MT,  Murphy SA, Harrington RA, Green CL, Schweiger MJ, Miklin JS, Baran KW, Palmeri S, Braunwald E, and Krucoff MW for the INTEGRITI Study Group.  Impaired TIMI epicardial flow and myocardial perfusion grades are associated with increased time to ST segment recovery in ST segment elevation MI: An INTEGRITI substudy.  Am Heart J. 2004;147(5):847-52.

 

15.  Giugliano RP, Sabatine MS, Gibson CM, Roe MT, Harrington RA, Murphy SA, DA Morrow, EM Antman, and E Braunwald. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. Am J Cardiol 2004 93(11): p. 1362.

 

16.  Gibson CM and Schomig A. Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. Circulation 2004 109(25): p. 3096-3105.

 

17.  Gibson CM, Jennings LK, Lorenz D, Giugliano RP, Harrington RA, Roe MT, Murphy SA, Cholera S, Baran KW, Hobbach H, Braunwald E.  Increased platelet receptor occupancy following eptifibatide therapy is associated with improved patency, tissue level perfusion and ST segment resolution in ST segment elevation myocardial infarction: An INTEGRITI substudy. Circulation 2004;110(6):679-84.

 

18.  Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, Barron HV, Giugliano RP, Antman EM, Braunwald E. Angiographic Perfusion Score: An Angiographic Variable That Integrates Both Epicardial and Tissue Level Perfusion Before and After Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Am Heart J. 2004 Aug;148(2):336-40.

 

19.  Gibson CM, Singh KP, Murphy SA, DiBattiste P, Demopoulos L, Cannon CP and Braunwald E for the TIMI Study Group. Association Between Duration of Tirofiban Therapy Before Percutaneous Intervention and Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy. Am J Cardiol 2004, Am J Cardiol. 2004 Aug 15;94(4):492-4.

 

 

20.  Gibson CM, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM, and Braunwald E for the TIMI Study Group. Association of Duration of Symptoms at Presentation with Angiographic and Clinical Outcomes Following Fibrinolytic Therapy. J Am Coll Cardiol. 2004 Sep 1;44(5):980-7.

 

21.  Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Rahman A, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, and Gibson CM for the TIMI Study Group. Association of  Epicardial and Tissue-level Reperfusion with Left Ventricular End-Diastolic Pressures in ST-Elevation Myocardial Infarction. Journal of Thrombosis and Thrombolysis 17(3), 177–184, 2004.

 

22.  Gibson CM. Time is myocardium and time is outcomes. Circulation 2001, Nov 27;104(22):2632-4.

 

23.  Gibson CM. Has My Patient Achieved Adequate Myocardial Reperfusion?  Circulation. 2003 Aug 5;108(5):504-7.

 

24.  Gibson CM. Confusion in reperfusion. J Am Coll Cardiol 2003, in press.

 

25.  Gibson CM, DeLemos JA, Antman EM. Time is muscle in primary PCI: the strength of the evidence grows  Eur Heart J. 2004 Jun;25(12):1001-2.

 

26.  Stone GW, Lansky AJ, Mehran R, Peterson MA, Gruberg L, Dangas G, Kartik E, Slack ST, Reed R, Proctor B, Leon MB. Beyond TIMI 3 Flow: The importance of restored myocardial perfusion for survival in high risk patients undergoing primary or rescue PTCA. J Am Coll Cardiol 2000; 35: 403A.

 

27.  Lepper W, Hoffman R, Kamp O, Franke A, de Cock CC, Kuehl HP, Siesverda GJ, Janssens U, Visser CA, Hanrath P. Angiographic myocardial blush grade relates to myocardial contrast echo and coronary flow reserve for assessment of reperfusion after myocardial infarction. J Am Coll Cardiol 2000; 35: 397A.

 

28.  Limbruno U, Micheli A, De Carlo M, Amoroso G, Rossini R, Palagi C, Di Bello V, Petronio AS, Fontanini G, Mariani M. Mechanical Prevention of Distal Embolization During Primary Angioplasty. Safety, Feasibility, and Impact on Myocardial Reperfusion. Circulation. 2003 Jun 30.

 

29.F Bellandi, M Maioli, M Gallopin, A Toso, and RP Dabizzi. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardiovasc Interv 1 Jun 2004 62(2): p. 186.

 

30.Leonardo Bolognese, Kenneth Ducci, Paolo Angioli, Giovanni Falsini,Francesco Liistro, Silvia Baldassarre, and Antonio Burali. Elevations in Troponin I After Percutaneous Coronary Interventions Are Associated With Abnormal Tissue-Level Perfusion in High-Risk Patients With Non-ST-Segment-Elevation Acute Coronary Syndromes. Circulation. 2004;  110(12): p. 1592-159.

 

31.Balachandran KP, Berry C, Norrie J, Vallance BD, Malekianpour M, Gilbert TJ, Pell ACH, and Oldroyd KG.  Relation between coronary pressure derived collateral flow, myocardial  perfusion grade, and outcome in left ventricular function after rescue percutaneous coronary intervention.     Heart. 2004;  90(12): p. 1450-1454.